
ST Pharm Co.,Ltd. 237690.KQ
237690.KQ
ST Pharm Co.,Ltd. 347850.KQ
D&D Pharmatech 006280.KS
GC Biopharma Corp. 226950.KQ
OliX Pharmaceuticals,Inc 009420.KS
Hanall Biopharma Co.,Ltd 039200.KQ
Oscotec Inc. 069620.KS
Daewoong pharmaceutical Co.,Ltd 068760.KQ
Celltrion Pharm, Inc. 008930.KS
Hanmi Science Co., Ltd. 290650.KQ
L&C Bio Co., Ltd
ST Pharm Co.,Ltd. 347850.KQ
D&D Pharmatech 006280.KS
GC Biopharma Corp. 226950.KQ
OliX Pharmaceuticals,Inc 009420.KS
Hanall Biopharma Co.,Ltd 039200.KQ
Oscotec Inc. 069620.KS
Daewoong pharmaceutical Co.,Ltd 068760.KQ
Celltrion Pharm, Inc. 008930.KS
Hanmi Science Co., Ltd. 290650.KQ
L&C Bio Co., Ltd
Performance
Periode | 237690.KQ | 347850.KQ | 006280.KS | 226950.KQ | 009420.KS | 039200.KQ | 069620.KS | 068760.KQ | 008930.KS | 290650.KQ |
---|---|---|---|---|---|---|---|---|---|---|
6M | 25.20 % | 187.65 % | 9.46 % | 78.39 % | 27.27 % | 28.64 % | 5.56 % | 23.31 % | 34.82 % | 135.46 % |
YTD | 11.12 % | 246.23 % | -24.19 % | 378.90 % | -9.09 % | 61.07 % | 9.38 % | 6.20 % | 29.28 % | 95.29 % |
1Y | -13.33 % | 240.68 % | -25.19 % | 213.10 % | -29.29 % | -0.76 % | -12.38 % | -6.56 % | 6.34 % | 156.04 % |
3Y | 17.89 % | 415.15 % | 8.92 % | 384.27 % | 164.15 % | 128.49 % | -7.84 % | 6.60 % | 24.21 % | 137.14 % |
5Y | 47.36 % | 415.15 % | -40.46 % | 185.53 % | 11.46 % | -5.34 % | 35.32 % | -32.72 % | -32.33 % | 16.08 % |
10Y | 94.47 % | 415.15 % | -27.39 % | 185.53 % | 168.20 % | 690.94 % | 82.26 % | 491.96 % | -63.89 % | 454.36 % |
From the beginning | 94.47 % | 415.15 % | 1 724.20 % | 185.53 % | 6 901.87 % | 512.69 % | 769.39 % | 431.40 % | 1 466.66 % | 454.36 % |